Tech Company Financing Transactions

Auron Therapeutics Funding Round

Auron Therapeutics, operating out of Newton, received $48 million from DCVC, Arkin Bio-Ventures and BrightEdge.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

55 Chapel St. 100
Newton, MA 02458
USA

Phone

Undisclosed

Website

www.aurontx.com

Email Address

Not Recorded

Overview

Auron was founded by a world class team of physicians and scientists with proven expertise in bringing effective differentiation therapies to patients. Their initial successes highlighted the untapped potential of this transformative approach.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kate Yen

        

Chief Scientific Officer

Thomas Graeber

        

Chief Scientific Officer

David Millan

        

VP - Human Resources

Andrea Armstrong

        

Browse more venture capital transactions:

Prev: 7/20/2022: Veremark venture capital transaction
Next: 7/20/2022: Crunchbase venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary